Busulfan Suppliers & Bulk Manufacturers
Available Forms: Injection (IV), Oral Tablet
Available Strengths: Injection: 6 mg/mL; Tablet: 2 mg
Reference Brands: US: Busulfex® (IV), Myleran® (oral); EU: Busilvex® (IV), Myleran® (tablet)
Category:
Oncology Cancer Care
Busulfan is an oncology drug used in pre-transplant conditioning for CML and other cancers, available as 6 mg/mL IV vials and 2 mg tablets in the US and EU.
Busulfan is available in Injection (IV), Oral Tablet
and strengths such as Injection: 6 mg/mL; Tablet: 2 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Busulfan is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Busulfan can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Busulfan, available in 6 mg/mL IV injection and 2 mg oral tablets, is a critical alkylating agent used in conditioning regimens prior to hematopoietic stem cell transplantation (HSCT). Approved in both the US and EU under brands like Busulfex® and Busilvex®, it plays a key role in treating chronic myelogenous leukemia (CML) and other hematologic cancers. Manufactured under strict GMP conditions, Busulfan is supplied in sterile, ready-to-infuse formulations, making it ideal for oncology-focused B2B partnerships, licensing, and supply in regulated markets. Reliable sourcing of Busulfan is essential for transplant protocols in cancer care facilities.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing